Human Gene OK/SW-cl.16 (uc004cou.2)
|
|
Sequence and Links to Tools and Databases
|
|
Primer design for this transcript
|
|
Microarray Expression Data
|
|
Orthologous Genes in Other Species
|
|
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Mouse | Rat | Zebrafish | D. melanogaster | C. elegans | S. cerevisiae |
No ortholog | No ortholog | No ortholog | No ortholog | No ortholog | No ortholog |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
|
| |
|
|
Descriptions from all associated GenBank mRNAs
|
|
HW291269 - JP 2013520965-A/31: UV ASSOCIATED mtDNA FUSION TRANSCRIPTS AND METHODS AND USES THEREOF. HW291270 - JP 2013520965-A/32: UV ASSOCIATED mtDNA FUSION TRANSCRIPTS AND METHODS AND USES THEREOF. HW291261 - JP 2013520965-A/23: UV ASSOCIATED mtDNA FUSION TRANSCRIPTS AND METHODS AND USES THEREOF. HW291262 - JP 2013520965-A/24: UV ASSOCIATED mtDNA FUSION TRANSCRIPTS AND METHODS AND USES THEREOF. HW291263 - JP 2013520965-A/25: UV ASSOCIATED mtDNA FUSION TRANSCRIPTS AND METHODS AND USES THEREOF. HW291276 - JP 2013520965-A/38: UV ASSOCIATED mtDNA FUSION TRANSCRIPTS AND METHODS AND USES THEREOF. HW291259 - JP 2013520965-A/21: UV ASSOCIATED mtDNA FUSION TRANSCRIPTS AND METHODS AND USES THEREOF. HW291271 - JP 2013520965-A/33: UV ASSOCIATED mtDNA FUSION TRANSCRIPTS AND METHODS AND USES THEREOF. HW291272 - JP 2013520965-A/34: UV ASSOCIATED mtDNA FUSION TRANSCRIPTS AND METHODS AND USES THEREOF. HW291264 - JP 2013520965-A/26: UV ASSOCIATED mtDNA FUSION TRANSCRIPTS AND METHODS AND USES THEREOF. X15759 - H.sapiens mitochondrial mRNA for cytochrome c oxidase subunit II. BC013387 - Homo sapiens, Similar to cytochrome c oxidase II, clone IMAGE:4050172, mRNA. BC013388 - Homo sapiens, Similar to cytochrome c oxidase II, clone IMAGE:3681696, mRNA. BC013390 - Homo sapiens, Similar to cytochrome c oxidase II, clone IMAGE:4041403, mRNA. BC013391 - Homo sapiens, Similar to cytochrome c oxidase II, clone IMAGE:4041785, mRNA. AB019563 - Homo sapiens mRNA expressed only in placental villi, clone SMAP42. AY211920 - Homo sapiens sarcoma antigen NY-SAR-71 mRNA, partial cds. X55654 - Homo sapiens mitochondrial coxII mRNA for cytochrome C oxidase II subunit. AK026536 - Homo sapiens cDNA: FLJ22883 fis, clone KAT03594, highly similar to MTHSCOXII Homo sapiens mitochondrial coxII mRNA for cytochrome C oxidase II subunit. Y17175 - Homo sapiens mRNA from HIV-associated non-Hodgkin's lymphoma (clone hl2-274). X64709 - H.sapiens deleted mitochondrial mRNA sequence (transcribed in human colon adenocarcinoma cells). AK026530 - Homo sapiens cDNA fis, A-KAT03057, highly similar to Homo sapiens mitochondrion, ATP synthase 6. AF368271 - Homo sapiens ATP synthase 6 mRNA, complete cds; mitochondrial gene for mitochondrial product. AK057071 - Homo sapiens cDNA FLJ32509 fis, clone SMINT1000054. Y17179 - Homo sapiens mRNA from HIV-associated non-Hodgkin's lymphoma (clone hl2-494). Y17171 - Homo sapiens mRNA from HIV-associated non-Hodgkin's lymphoma (clone hl2-129). AK094841 - Homo sapiens cDNA FLJ37522 fis, clone BRCAN2006174, weakly similar to ATP SYNTHASE A CHAIN (EC 3.6.1.34). BC036586 - Homo sapiens cDNA clone IMAGE:4798970, **** WARNING: chimeric clone ****. AB064665 - Homo sapiens mRNA for OK/SW-CL.16, complete cds. HV963896 - JP 2012521745-A/40: Aberrant Mitochondrial DNA, Associated Fusion Transcripts and Translation Products and Hybridization Probes Therefor. HV963894 - JP 2012521745-A/38: Aberrant Mitochondrial DNA, Associated Fusion Transcripts and Translation Products and Hybridization Probes Therefor. HV963885 - JP 2012521745-A/29: Aberrant Mitochondrial DNA, Associated Fusion Transcripts and Translation Products and Hybridization Probes Therefor. HV963886 - JP 2012521745-A/30: Aberrant Mitochondrial DNA, Associated Fusion Transcripts and Translation Products and Hybridization Probes Therefor. HV963877 - JP 2012521745-A/21: Aberrant Mitochondrial DNA, Associated Fusion Transcripts and Translation Products and Hybridization Probes Therefor. HV963878 - JP 2012521745-A/22: Aberrant Mitochondrial DNA, Associated Fusion Transcripts and Translation Products and Hybridization Probes Therefor. HV963879 - JP 2012521745-A/23: Aberrant Mitochondrial DNA, Associated Fusion Transcripts and Translation Products and Hybridization Probes Therefor. HV963891 - JP 2012521745-A/35: Aberrant Mitochondrial DNA, Associated Fusion Transcripts and Translation Products and Hybridization Probes Therefor. HV963875 - JP 2012521745-A/19: Aberrant Mitochondrial DNA, Associated Fusion Transcripts and Translation Products and Hybridization Probes Therefor. HV963887 - JP 2012521745-A/31: Aberrant Mitochondrial DNA, Associated Fusion Transcripts and Translation Products and Hybridization Probes Therefor. HV963892 - JP 2012521745-A/36: Aberrant Mitochondrial DNA, Associated Fusion Transcripts and Translation Products and Hybridization Probes Therefor. HV963880 - JP 2012521745-A/24: Aberrant Mitochondrial DNA, Associated Fusion Transcripts and Translation Products and Hybridization Probes Therefor. JA760640 - Sequence 59 from Patent EP2411522. JA760637 - Sequence 56 from Patent EP2411522. JA760610 - Sequence 29 from Patent EP2411522. JA760611 - Sequence 30 from Patent EP2411522. JA760602 - Sequence 21 from Patent EP2411522. JA760603 - Sequence 22 from Patent EP2411522. JA760604 - Sequence 23 from Patent EP2411522. JA760616 - Sequence 35 from Patent EP2411522. JA760600 - Sequence 19 from Patent EP2411522. JA760612 - Sequence 31 from Patent EP2411522. JA760634 - Sequence 53 from Patent EP2411522. JA760605 - Sequence 24 from Patent EP2411522. JB242127 - Sequence 31 from Patent EP2542680. JB242128 - Sequence 32 from Patent EP2542680. JB242119 - Sequence 23 from Patent EP2542680. JB242120 - Sequence 24 from Patent EP2542680. JB242121 - Sequence 25 from Patent EP2542680. JB242134 - Sequence 38 from Patent EP2542680. JB242117 - Sequence 21 from Patent EP2542680. JB242129 - Sequence 33 from Patent EP2542680. JB242130 - Sequence 34 from Patent EP2542680. JB242122 - Sequence 26 from Patent EP2542680. HV444972 - JP 2011515091-A/28: ABERRANT MITOCHONDRIAL DNA, ASSOCIATED FUSION TRANSCRIPTS AND HYBRIDIZATION PROBES THEREFOR. HV444973 - JP 2011515091-A/29: ABERRANT MITOCHONDRIAL DNA, ASSOCIATED FUSION TRANSCRIPTS AND HYBRIDIZATION PROBES THEREFOR. JA040733 - Sequence 28 from Patent EP2274426. JA040734 - Sequence 29 from Patent EP2274426. HV444964 - JP 2011515091-A/20: ABERRANT MITOCHONDRIAL DNA, ASSOCIATED FUSION TRANSCRIPTS AND HYBRIDIZATION PROBES THEREFOR. HV444965 - JP 2011515091-A/21: ABERRANT MITOCHONDRIAL DNA, ASSOCIATED FUSION TRANSCRIPTS AND HYBRIDIZATION PROBES THEREFOR. HV444966 - JP 2011515091-A/22: ABERRANT MITOCHONDRIAL DNA, ASSOCIATED FUSION TRANSCRIPTS AND HYBRIDIZATION PROBES THEREFOR. JA040725 - Sequence 20 from Patent EP2274426. JA040726 - Sequence 21 from Patent EP2274426. JA040727 - Sequence 22 from Patent EP2274426. BD353340 - Method for predicting functional sites of RNA from its sequence. M37726 - Human mitochondrial Lys-tRNA-aaa. HV444977 - JP 2011515091-A/33: ABERRANT MITOCHONDRIAL DNA, ASSOCIATED FUSION TRANSCRIPTS AND HYBRIDIZATION PROBES THEREFOR. JA040738 - Sequence 33 from Patent EP2274426. HV444962 - JP 2011515091-A/18: ABERRANT MITOCHONDRIAL DNA, ASSOCIATED FUSION TRANSCRIPTS AND HYBRIDIZATION PROBES THEREFOR. JA040723 - Sequence 18 from Patent EP2274426. HV444974 - JP 2011515091-A/30: ABERRANT MITOCHONDRIAL DNA, ASSOCIATED FUSION TRANSCRIPTS AND HYBRIDIZATION PROBES THEREFOR. HV444978 - JP 2011515091-A/34: ABERRANT MITOCHONDRIAL DNA, ASSOCIATED FUSION TRANSCRIPTS AND HYBRIDIZATION PROBES THEREFOR. JA040735 - Sequence 30 from Patent EP2274426. JA040755 - Sequence 50 from Patent EP2274426. HV444967 - JP 2011515091-A/23: ABERRANT MITOCHONDRIAL DNA, ASSOCIATED FUSION TRANSCRIPTS AND HYBRIDIZATION PROBES THEREFOR. JA040728 - Sequence 23 from Patent EP2274426. DL492475 - Novel nucleic acids. JD410911 - Sequence 391935 from Patent EP1572962. JD398518 - Sequence 379542 from Patent EP1572962. JD285308 - Sequence 266332 from Patent EP1572962. JD113307 - Sequence 94331 from Patent EP1572962. JD130444 - Sequence 111468 from Patent EP1572962. JD097059 - Sequence 78083 from Patent EP1572962. LY485908 - KR 1020170004033-A/28: ABERRANT MITOCHONDRIAL DNA, ASSOCIATED FUSION TRANSCRIPTS AND HYBRIDIZATION PROBES THEREFOR. LY485909 - KR 1020170004033-A/29: ABERRANT MITOCHONDRIAL DNA, ASSOCIATED FUSION TRANSCRIPTS AND HYBRIDIZATION PROBES THEREFOR. LY485900 - KR 1020170004033-A/20: ABERRANT MITOCHONDRIAL DNA, ASSOCIATED FUSION TRANSCRIPTS AND HYBRIDIZATION PROBES THEREFOR. LY485901 - KR 1020170004033-A/21: ABERRANT MITOCHONDRIAL DNA, ASSOCIATED FUSION TRANSCRIPTS AND HYBRIDIZATION PROBES THEREFOR. LY485902 - KR 1020170004033-A/22: ABERRANT MITOCHONDRIAL DNA, ASSOCIATED FUSION TRANSCRIPTS AND HYBRIDIZATION PROBES THEREFOR. LY485913 - KR 1020170004033-A/33: ABERRANT MITOCHONDRIAL DNA, ASSOCIATED FUSION TRANSCRIPTS AND HYBRIDIZATION PROBES THEREFOR. LY485898 - KR 1020170004033-A/18: ABERRANT MITOCHONDRIAL DNA, ASSOCIATED FUSION TRANSCRIPTS AND HYBRIDIZATION PROBES THEREFOR. LY485910 - KR 1020170004033-A/30: ABERRANT MITOCHONDRIAL DNA, ASSOCIATED FUSION TRANSCRIPTS AND HYBRIDIZATION PROBES THEREFOR. LY485914 - KR 1020170004033-A/50: ABERRANT MITOCHONDRIAL DNA, ASSOCIATED FUSION TRANSCRIPTS AND HYBRIDIZATION PROBES THEREFOR. LY485903 - KR 1020170004033-A/23: ABERRANT MITOCHONDRIAL DNA, ASSOCIATED FUSION TRANSCRIPTS AND HYBRIDIZATION PROBES THEREFOR. LP895143 - Sequence 7 from Patent EP3253886. LP790441 - Sequence 59 from Patent EP3272871. LP790438 - Sequence 56 from Patent EP3272871. LP790411 - Sequence 29 from Patent EP3272871. LP790412 - Sequence 30 from Patent EP3272871. LP803417 - Sequence 31 from Patent EP3305902. LP803418 - Sequence 32 from Patent EP3305902. LP790403 - Sequence 21 from Patent EP3272871. LP790404 - Sequence 22 from Patent EP3272871. LP790405 - Sequence 23 from Patent EP3272871. LP803409 - Sequence 23 from Patent EP3305902. LP803410 - Sequence 24 from Patent EP3305902. LP803411 - Sequence 25 from Patent EP3305902. LP790417 - Sequence 35 from Patent EP3272871. LP803424 - Sequence 38 from Patent EP3305902. LP790401 - Sequence 19 from Patent EP3272871. LP803407 - Sequence 21 from Patent EP3305902. LP790413 - Sequence 31 from Patent EP3272871. LP790435 - Sequence 53 from Patent EP3272871. LP803419 - Sequence 33 from Patent EP3305902. LP803420 - Sequence 34 from Patent EP3305902. LP790406 - Sequence 24 from Patent EP3272871. LP803412 - Sequence 26 from Patent EP3305902.
| |
|
|
Other Names for This Gene
|
|
Alternate Gene Symbols: AB064665, uc004cou.1 UCSC ID: uc004cou.2 Representative RNA: AB064665
| |
|
|
Gene Model Information
|
|
category:
| noncoding
| nonsense-mediated-decay:
| no
| RNA accession:
| AB064665.1
|
exon count:
| 1 | CDS single in 3' UTR:
| no
| RNA size:
| 1015 |
ORF size:
| 0 | CDS single in intron:
| no
| Alignment % ID:
| 99.68 |
txCdsPredict score:
| 311.00 | frame shift in genome:
| no
| % Coverage:
| 16.95 |
has start codon:
| no
| stop codon in genome:
| no
| # of Alignments:
| 1 |
has end codon:
| no
| retained intron:
| no
| # AT/AC introns
| 0 |
selenocysteine:
| no
| end bleed into intron:
| 0 | # strange splices:
| 0 |
|
Click here
for a detailed description of the fields of the table above.
| |
|
|
Methods, Credits, and Use Restrictions
|
|
Click here
for details on how this gene model was made and data restrictions if any.
| |
|
|
|